SCIENCE BLOG




Placeholder image
New Research Reveals Blood-Brain Barrier Breakdown as a Silent Trigger of Dementia and ALS

Mutations in a single protein can destabilize brain blood vessels and launch a cascade leading to neurodegenerative disease—before neurons are even harmed.

MAY 07, 2025 | BY SciSoup Desk

A ground-breaking study from the University of Connecticut School of Medicine is reshaping our understanding of neurodegenerative disease, revealing that the breakdown of the brain’s vascular system—specifically the blood-brain barrier (BBB)—may be an initiating event in conditions like ALS (amyotrophic lateral sclerosis), fronto-temporal dementia (FTD), and possibly Alzheimer’s disease.

The research, led by Dr. Ashok Cheemala in Dr. Patrick Murphy’s lab, focuses on TDP-43, a protein long known for its role in neuron health. But here, researchers discovered that TDP-43 is just as crucial in the endothelial cells that line the brain’s blood vessels. When TDP-43 is lost or mutated in these cells, the consequences are immediate and severe: the blood-brain barrier weakens, allowing harmful substances into the brain and setting off inflammation, glial activation, and pTau accumulation—long before neurons show any damage. The results of this study have been published in the journal Science Advances.

According to this study, researchers used mice with a genetic mutation linked to ALS and FTD in humans. They found that these mice experienced problems with their brain’s blood-brain barrier (BBB) as they aged. The cells lining the blood vessels in the brain (called endothelial cells) lost important proteins, making the barrier weaker. This suggested that the problem started directly in the blood vessel cells, not as a result of other failing systems.

In a key experiment, the team used a genetic tool to remove TDP-43 from just the blood vessel cells in the brain. This caused the blood-brain barrier to quickly become leaky, allowing harmful substances to enter. Over time, the mice developed typical signs of FTD, like brain inflammation, changes in behavior (including memory problems and social issues), and buildup of abnormal proteins—yet their brain cells (neurons) remained healthy.

“This was a ‘eureka’ moment,” said Cheemala. “We saw signs of disease—like brain inflammation—before any neurons were affected, showing that damage to the blood vessels could be the starting point for neurodegenerative diseases.”

To further support their findings, the researchers compared gene data from their mouse models to human brain tissue from ALS, FTD, and Alzheimer’s patients. They found that the same pathways in the brain were disrupted, especially those that control the stability of cells and the brain’s protective barrier. This suggests that issues with TDP-43 in the blood vessels might not only be seen in rare genetic cases but could also be present in more common, non-genetic forms of these diseases.

The study also showed that when TDP-43 is missing in the blood vessels, it weakens the connections between cells, breaking down the blood-brain barrier. This allows harmful substances to enter the brain, triggering immune cells to attack and causing damage to nearby neurons.


“Prof. Chris B. Schaffer from Meinig School of Biomedical Engineering, Cornell University, commented, “This research shows that problems in the blood vessels can cause neurodegenerative changes on their own. It’s a big deal because it shifts how we think about the role of blood vessels in these diseases.” He is not involved in this study.”

The findings could change how we diagnose and treat neurodegenerative diseases like ALS, FTD, and Alzheimer’s. Instead of just focusing on neurons, doctors might be able to intervene earlier by protecting or repairing the blood-brain barrier.

Cheemala said, “Our research shows that neurons don’t degrade by themselves—they depend on healthy blood vessels to survive.” This new understanding opens up exciting possibilities for preventing or slowing down these diseases by focusing on the brain’s blood vessels.

Journal Reference:
Amyotrophic lateral sclerosis and frontotemporal dementia mutation reduces endothelial TDP-43 and causes blood-brain barrier defects

Disclaimer:
SciSoup claims no competing interest. To ensure accuracy and scientific relevance, this science blog has been reviewed by the research team involved in the study.